SynthesisWorld journal of surgical oncology2025

TAS-102 plus bevacizumab versus TAS-102 alone for metastatic colorectal cancer: a systematic review and meta-analysis.

Jing Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.